Deutsche Bank Maintains Hold on AmSurg

Deutsche Bank is out with its report today on AmSurg

, maintaining Hold. In its report, Deutsche Bank writes, "Q3 results, exc. NSC transaction costs, were slightly better than expected; EPS of $0.45 (Street $0.43) and SS revs continuing recent positive trend at +1% yoy. With the NSC transaction progressing well and a few tailwinds (like pricing, easier comps and M&A accretion), mgmt is expressing a slightly more upbeat tone about 2012 prospects. We see slightly better operating momentum into 2012, yet maintain Hold / $29 PT due to mixed sector fundamentals." At the time of posting, shares of AMSG were trading at $24.81, down 0.28% from Tuesday's close.